Articles with public access mandates - Zheng Xiong XiLearn more
Not available anywhere: 2
Inhibition of NAALADase by 2‐PMPA attenuates cocaine‐induced relapse in rats: a NAAG‐mGluR2/3‐mediated mechanism
ZX Xi, X Li, XQ Peng, J Li, L Chun, EL Gardner, AG Thomas, BS Slusher, ...
Journal of neurochemistry 112 (2), 564-576, 2010
Mandates: US National Institutes of Health
Modifications to 1-(4-(2-Bis (4-fluorophenyl) methyl) sulfinyl) alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile
AV Okorom, GA Camacho-Hernandez, K Salomon, KH Lee, TC Ku, J Cao, ...
Journal of medicinal chemistry 67 (1), 709-727, 2023
Mandates: Danish Council for Independent Research
Available somewhere: 107
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
ZX Xi, XQ Peng, X Li, R Song, HY Zhang, QR Liu, HJ Yang, GH Bi, J Li, ...
Nature neuroscience 14 (9), 1160-1166, 2011
Mandates: US National Institutes of Health
Local cues establish and maintain region-specific phenotypes of basal ganglia microglia
LM De Biase, KE Schuebel, ZH Fusfeld, K Jair, IA Hawes, R Cimbro, ...
Neuron 95 (2), 341-356. e6, 2017
Mandates: US National Institutes of Health
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
HY Zhang, M Gao, QR Liu, GH Bi, X Li, HJ Yang, EL Gardner, J Wu, ZX Xi
Proceedings of the National Academy of Sciences 111 (46), E5007-E5015, 2014
Mandates: US National Institutes of Health
Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus
AV Stempel, A Stumpf, HY Zhang, T Özdoğan, U Pannasch, AK Theis, ...
Neuron 90 (4), 795-809, 2016
Mandates: US National Institutes of Health, German Research Foundation
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by …
QR Liu, CH Pan, A Hishimoto, CY Li, ZX Xi, A Llorente‐Berzal, ...
Genes, Brain and Behavior 8 (5), 519-530, 2009
Mandates: US National Institutes of Health
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
CJ Jordan, ZX Xi
Neuroscience & Biobehavioral Reviews 98, 208-220, 2019
Mandates: US National Institutes of Health
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
HY Zhang, M Gao, H Shen, GH Bi, HJ Yang, QR Liu, J Wu, EL Gardner, ...
Addiction biology 22 (3), 752-765, 2017
Mandates: US National Institutes of Health
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
QR Liu, A Canseco-Alba, HY Zhang, P Tagliaferro, M Chung, E Dennis, ...
Scientific reports 7 (1), 17410, 2017
Mandates: US National Institutes of Health
Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats
HY Zhang, GH Bi, X Li, J Li, H Qu, SJ Zhang, CY Li, ES Onaivi, ...
Neuropsychopharmacology 40 (4), 1037-1051, 2015
Mandates: US National Institutes of Health, National Natural Science Foundation of China
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
E Galaj, GH Bi, HJ Yang, ZX Xi
Neuropharmacology 167, 107740, 2020
Mandates: US National Institutes of Health
Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats
ZX Xi, K Spiller, AC Pak, J Gilbert, C Dillon, X Li, XQ Peng, EL Gardner
Neuropsychopharmacology 33 (7), 1735-1745, 2008
Mandates: US National Institutes of Health
Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope
SYA Tsai, JY Chuang, MS Tsai, X Wang, ZX Xi, JJ Hung, WC Chang, ...
Proceedings of the National Academy of Sciences 112 (47), E6562-E6570, 2015
Mandates: US National Institutes of Health
YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self‐administration in rats and mice, but not in D3 receptor‐knockout mice
R Song, RF Yang, N Wu, RB Su, J Li, XQ Peng, X Li, J Gaál, ZX Xi, ...
Addiction biology 17 (2), 259-273, 2012
Mandates: US National Institutes of Health
Discovery and development of varenicline for smoking cessation
CJ Jordan, ZX Xi
Expert opinion on drug discovery 13 (7), 671-683, 2018
Mandates: US National Institutes of Health
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid …
V Kumar, A Bonifazi, MP Ellenberger, TM Keck, E Pommier, R Rais, ...
Journal of medicinal chemistry 59 (16), 7634-7650, 2016
Mandates: US National Institutes of Health
Increased vulnerability to cocaine in mice lacking dopamine D3 receptors
R Song, HY Zhang, X Li, GH Bi, EL Gardner, ZX Xi
Proceedings of the National Academy of Sciences 109 (43), 17675-17680, 2012
Mandates: US National Institutes of Health
Hypothesis-driven medication discovery for the treatment of psychostimulant addiction
ZX Xi, EL Gardner
Current drug abuse reviews 1 (3), 303-327, 2008
Mandates: US National Institutes of Health
Lower glutamate levels in rostral anterior cingulate of chronic cocaine users—A 1H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy
S Yang, BJ Salmeron, TJ Ross, ZX Xi, EA Stein, Y Yang
Psychiatry Research: Neuroimaging 174 (3), 171-176, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program